DVT Prophylaxis in Medical Patients. Rog Kyle, MD MUSC 6/5/12. Review risks for developing DVT and bleeding from DVT prophylaxis Review current recommendations for inpatient DVT prophylaxis (AT9) Review different pharmacologic and mechanical methods for DVT prophylaxis
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Rog Kyle, MD
“BID heparin dosing causes fewer major bleeding episodes, while TID dosing appears to offer somewhat better efficacy in preventing clinically relevant VTE events”
“Moderate-quality evidence suggests that subcutaneous UFH bid and UFH tid do not differ in effect on DVT, PE, major bleeding, and mortality”
N Engl J Med 2011;365:2463-72